Skip to main content
Top
Published in: International Journal of Legal Medicine 3/2007

01-05-2007 | Original Article

Medicolegal aspects of tetrazepam metabolism

Authors: Marion Pavlic, Kathrin Libiseller, Petra Grubwieser, Heinrich Schubert, Walter Rabl

Published in: International Journal of Legal Medicine | Issue 3/2007

Login to get access

Abstract

The benzodiazepine tetrazepam is primarily muscle relaxant with comparably lower central sedating effects and is therefore commonly prescribed for muscle spasms of different origins. To evaluate tetrazepam metabolism, a study was conducted with ten healthy volunteers. Blood and urine samples were regularly collected after the intake of 50 mg tetrazepam. Toxicological analyses revealed that tetrazepam is also metabolized to diazepam and further to nordazepam, which has not yet been reported. Tetrazepam and diazepam could be detected in urine samples at least 72 h after intake, the diazepam concentration being 33% (±14% SD), on average, of the tetrazepam concentration. On the basis of three case histories, the importance of the detection of these newly described metabolites is shown as necessary to prevent false accusations and potential negative legal consequences for examined persons.
Literature
1.
go back to reference Keane PE, Simiand J, Morre M, Biziere K (1988) Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents. J Pharmacol Exp Ther 245:692–698PubMed Keane PE, Simiand J, Morre M, Biziere K (1988) Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents. J Pharmacol Exp Ther 245:692–698PubMed
2.
go back to reference Keane PE, Bachy A, Morre M, Biziere K (1988) Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. II. In vitro and in vivo interactions with benzodiazepine binding sites. J Pharmacol Exp Ther 245:699–705PubMed Keane PE, Bachy A, Morre M, Biziere K (1988) Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. II. In vitro and in vivo interactions with benzodiazepine binding sites. J Pharmacol Exp Ther 245:699–705PubMed
3.
go back to reference Milanov I (1992) Mechanisms of tetrazepam action on spasticity. Acta Neurol Belg 92:5–15PubMed Milanov I (1992) Mechanisms of tetrazepam action on spasticity. Acta Neurol Belg 92:5–15PubMed
4.
go back to reference Lobisch M, Schaffler K, Wauschkuhn H, Nickel B (1996) Clinical pilot study of the myogenic effects of flupirtine in comparison to tetrazepam and placebo (in German). Arzneimittelforschung 46:293–298PubMed Lobisch M, Schaffler K, Wauschkuhn H, Nickel B (1996) Clinical pilot study of the myogenic effects of flupirtine in comparison to tetrazepam and placebo (in German). Arzneimittelforschung 46:293–298PubMed
5.
go back to reference Simiand J, Keane PE, Biziere K, Soubrie P (1989) Comparative study in mice of tetrazepam and other centrally active skeletal muscle relaxants. Arch Int Pharmacodyn Ther 297:272–285PubMed Simiand J, Keane PE, Biziere K, Soubrie P (1989) Comparative study in mice of tetrazepam and other centrally active skeletal muscle relaxants. Arch Int Pharmacodyn Ther 297:272–285PubMed
6.
go back to reference Perez-Guerrero C, Suarez J, Herrera MD, Marhuenda E (1997) Vasodilating effects of tetrazepam in isolated vascular smooth muscles: comparison with cromakalim and diltiazem. Pharmacol Res 36:237–242PubMedCrossRef Perez-Guerrero C, Suarez J, Herrera MD, Marhuenda E (1997) Vasodilating effects of tetrazepam in isolated vascular smooth muscles: comparison with cromakalim and diltiazem. Pharmacol Res 36:237–242PubMedCrossRef
7.
go back to reference Pellkofer M, Paulig M (1989) Comparative double-blind study of the effectiveness and tolerance of baclofen, tetrazepam and tizanidine in spastic movement disorders of the lower extremities (in German). Med Klin (Munich) 84:5–8 Pellkofer M, Paulig M (1989) Comparative double-blind study of the effectiveness and tolerance of baclofen, tetrazepam and tizanidine in spastic movement disorders of the lower extremities (in German). Med Klin (Munich) 84:5–8
8.
go back to reference Rote Liste (2005) Tetrazepam. Rote Liste Win 2005/II version 4.2 Rote Liste Service GmbH Rote Liste (2005) Tetrazepam. Rote Liste Win 2005/II version 4.2 Rote Liste Service GmbH
9.
go back to reference Baumgartner MG, Cautreels W, Langenbahn H (1984) Biotransformation and pharmacokinetics of tetrazepam in man. Arzneimittelforschung 34:724–729PubMed Baumgartner MG, Cautreels W, Langenbahn H (1984) Biotransformation and pharmacokinetics of tetrazepam in man. Arzneimittelforschung 34:724–729PubMed
10.
go back to reference Dussy FE, Hamberg C, Briellmann TA (2005) Quantification of benzodiazepines in whole blood and serum. Int J Legal Med Oct 12:1–8 Dussy FE, Hamberg C, Briellmann TA (2005) Quantification of benzodiazepines in whole blood and serum. Int J Legal Med Oct 12:1–8
11.
go back to reference Maurer H, Pfleger K (1987) Identification and differentiation of benzodiazepines and their metabolites in urine by computerized gas chromatography–mass spectrometry. J Chromatogr 422:85–101PubMedCrossRef Maurer H, Pfleger K (1987) Identification and differentiation of benzodiazepines and their metabolites in urine by computerized gas chromatography–mass spectrometry. J Chromatogr 422:85–101PubMedCrossRef
12.
go back to reference Staak M, Sticht G, Saternus KS, Kaferstein H (1982) Pharmacokinetic studies following administration of tetrazepam in rhesus monkeys. Beitr Gerichtl Med 40:323–328PubMed Staak M, Sticht G, Saternus KS, Kaferstein H (1982) Pharmacokinetic studies following administration of tetrazepam in rhesus monkeys. Beitr Gerichtl Med 40:323–328PubMed
13.
go back to reference Bun H, Philip F, Berger Y, Necciari J, Al Mallah NR, Serradimign A, Cano JP (1987) Plasma levels and pharmacokinetics of single and multiple dose of tetrazepam in healthy volunteers. Arzneimittelforschung 37:199–202PubMed Bun H, Philip F, Berger Y, Necciari J, Al Mallah NR, Serradimign A, Cano JP (1987) Plasma levels and pharmacokinetics of single and multiple dose of tetrazepam in healthy volunteers. Arzneimittelforschung 37:199–202PubMed
14.
go back to reference Staak M, Sticht G, Kaferstein H, Norpoth T (1984) Pharmacokinetics and metabolite pattern of tetrazepam and chlordesmethyldiazepam. Beitr Gerichtl Med 42:75–79PubMed Staak M, Sticht G, Kaferstein H, Norpoth T (1984) Pharmacokinetics and metabolite pattern of tetrazepam and chlordesmethyldiazepam. Beitr Gerichtl Med 42:75–79PubMed
15.
go back to reference Schulz M, Schmoldt A (2003) Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58:447–474PubMed Schulz M, Schmoldt A (2003) Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58:447–474PubMed
16.
go back to reference Geister U, Gaupp M, Arnold P, Schaarschmidt D, Doser K (2000) Bioavailability investigation of two different oral formulations of tetrazepam. Arzneimittelforschung 50:328–332PubMed Geister U, Gaupp M, Arnold P, Schaarschmidt D, Doser K (2000) Bioavailability investigation of two different oral formulations of tetrazepam. Arzneimittelforschung 50:328–332PubMed
17.
go back to reference Concheiro M, Villain M, Bouchet S, Ludes B, Lopez-Rivadulla M, Kintz P (2005) Windows of detection of tetrazepam in urine, oral fluid, beard, and hair, with a special focus on drug-facilitated crimes. Ther Drug Monit 27:565–570PubMedCrossRef Concheiro M, Villain M, Bouchet S, Ludes B, Lopez-Rivadulla M, Kintz P (2005) Windows of detection of tetrazepam in urine, oral fluid, beard, and hair, with a special focus on drug-facilitated crimes. Ther Drug Monit 27:565–570PubMedCrossRef
18.
go back to reference Musshoff F, Dettmeyer R, Madea B (1998) Death in the bathtub—rectal drug administration. Arch Kriminol 201:80–86PubMed Musshoff F, Dettmeyer R, Madea B (1998) Death in the bathtub—rectal drug administration. Arch Kriminol 201:80–86PubMed
19.
go back to reference Boccardi G, Deleuze C, Gachon M, Palmisano G, Vergnaud JP (1992) Autoxidation of tetrazepam in tablets: prediction of degradation impurities from the oxidative behavior in solution. J Pharm Sci 81:183–185PubMedCrossRef Boccardi G, Deleuze C, Gachon M, Palmisano G, Vergnaud JP (1992) Autoxidation of tetrazepam in tablets: prediction of degradation impurities from the oxidative behavior in solution. J Pharm Sci 81:183–185PubMedCrossRef
20.
go back to reference Hammad MA, Muller BW (1998) Solubility and stability of tetrazepam in mixed micelles. Eur J Pharm Sci 7:49–55PubMedCrossRef Hammad MA, Muller BW (1998) Solubility and stability of tetrazepam in mixed micelles. Eur J Pharm Sci 7:49–55PubMedCrossRef
21.
go back to reference Guengerich FP (1991) Reactions and significance of cytochrome P-450 enzymes. J Biol Chem 266:10019–10022PubMed Guengerich FP (1991) Reactions and significance of cytochrome P-450 enzymes. J Biol Chem 266:10019–10022PubMed
22.
go back to reference Porter TD, Coon MJ (1991) Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J Biol Chem 266:13469–13472PubMed Porter TD, Coon MJ (1991) Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J Biol Chem 266:13469–13472PubMed
23.
go back to reference Schütz H (1989) Benzodiazepines II. A handbook, 1st edn. Springer, Berlin Heidelberg New York, p 32 Schütz H (1989) Benzodiazepines II. A handbook, 1st edn. Springer, Berlin Heidelberg New York, p 32
24.
go back to reference He YA, Roussel F, Halpert JR (2003) Analysis of homotropic and heterotropic cooperativity of diazepam oxidation by CYP3A4 using site-directed mutagenesis and kinetic modeling. Arch Biochem Biophys 409:92–101PubMedCrossRef He YA, Roussel F, Halpert JR (2003) Analysis of homotropic and heterotropic cooperativity of diazepam oxidation by CYP3A4 using site-directed mutagenesis and kinetic modeling. Arch Biochem Biophys 409:92–101PubMedCrossRef
25.
go back to reference Steentoft A, Worm K, Pedersen CB, Sprehn M, Mogensen T, Sorensen MB, Nielsen E (1996) Drugs in blood samples from unconscious drug addicts after the intake of an overdose. Int J Legal Med 108:248–251PubMedCrossRef Steentoft A, Worm K, Pedersen CB, Sprehn M, Mogensen T, Sorensen MB, Nielsen E (1996) Drugs in blood samples from unconscious drug addicts after the intake of an overdose. Int J Legal Med 108:248–251PubMedCrossRef
26.
go back to reference Kaa E, Teige B (1993) Drug-related deaths during the 1980s. A comparative study of drug addict deaths examined at the institutes of forensic medicine in Aarhus, Denmark and Oslo, Norway. Int J Legal Med 106:5–9PubMedCrossRef Kaa E, Teige B (1993) Drug-related deaths during the 1980s. A comparative study of drug addict deaths examined at the institutes of forensic medicine in Aarhus, Denmark and Oslo, Norway. Int J Legal Med 106:5–9PubMedCrossRef
27.
go back to reference Favretto D, Frison G, Maietti S, Ferrara SD (2006) LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor. Int J Legal Med (in press) DOI 10.1007/s00414-006-0078-x Favretto D, Frison G, Maietti S, Ferrara SD (2006) LC-ESI-MS/MS on an ion trap for the determination of LSD, iso-LSD, nor-LSD and 2-oxo-3-hydroxy-LSD in blood, urine and vitreous humor. Int J Legal Med (in press) DOI 10.​1007/​s00414-006-0078-x
Metadata
Title
Medicolegal aspects of tetrazepam metabolism
Authors
Marion Pavlic
Kathrin Libiseller
Petra Grubwieser
Heinrich Schubert
Walter Rabl
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
International Journal of Legal Medicine / Issue 3/2007
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-006-0118-6

Other articles of this Issue 3/2007

International Journal of Legal Medicine 3/2007 Go to the issue